Protecting Democracy [1]

American democracy is in jeopardy, from the disastrous Citizens United ruling that flooded our politics with corporate cash to the immoral assault on voting rights. We work every day to defend against these threats and advance bold reforms.

Tell Congress: Pass the Protecting Our Democracy Act

Add Your Name

Generative Artificial Intelligence and Threats to Democracy

Protecting Elected Officials from Threats
Making Government Work [2]

The U.S. government should work for the public, not corporations or industry. It should safeguard consumers, workers and the environment, and be funded well enough to do so. The budget process must not be obstructed by partisanship.

Get Corporate Money Out of Politics

Sign the Petition

It’s Time to Cut the Bloated Pentagon Budget to Fund People, Not Military Contractors

Ensuring Public Money Does Not Go To Private Equity
Consumer & Worker Safeguards [3]

Every day, Big Banks, Big Polluters, and Big Tech companies are threatening our economy, our environment, and our democracy – sacrificing Main Street Americans and our families on the altar of corporate profits. Public Citizen advocates for ordinary people by taking on corporate interests and their cronies in government.

Don’t Let Big Tech Write Our Digital Privacy Laws

Sign Now

Public Citizen Calls on Presidential Candidates, Parties to Pledge Not to Use Dangerous, Manipulative Deepfakes

Within Reach: Banker Pay Reform
Safe & Affordable Drugs & Devices [4]

Prescription drugs are unaffordable and new drugs and devices often are approved without being proven safe and effective. Public Citizen challenges Big Pharma, device manufacturers and federal regulators to make drugs and medical devices safe, effective and accessible to all.

Tell President Biden: Make Meds Affordable

SEND AN EMAIL
Health Care [5]

Health care in the U.S. leaves too many people out, costs too much and doesn’t meet acceptable standards of quality. Much of the care that we get is unaffordable, unnecessary or harmful. Public Citizen advocates Medicare for All, stronger oversight of dangerous doctors and safe clinical trials.

Win Medicare for All

Take Action Now

Report: Ranking of the Rate of State Medical Boards’ Serious Disciplinary Actions, 2019-2021

Petition to the FDA to Strengthen Safety Warning for Botox and Related Drugs and Remove Misleading Claims From Botox/Botox Cosmetic Labeling
Globalization & Trade [6]

Global Trade Watch’s mission is to ensure that in this era of globalization, a majority have the opportunity to enjoy economic security, a healthy environment, safe food, medicines and products, access to quality affordable services such as health care and the exercise of democratic decision-making about the matters that affect our lives. Global Trade Watch has led the fight against corporate-rigged “trade” agreements that provide special powers for Big Pharma to raise medicine prices, promote the outsourcing of jobs to low-wage countries and undermine the food safety and other safeguards on which our families rely. For decades, we have fought for progressive alternatives that benefit people and the planet.

President Biden: No Secrecy in Indo-Pacific Trade Talks

Take Action

Climate Peace Clause Needed to Stop Trade Attacks on Climate Policies

Big Tech’s “Digital Trade” Power-Grab
Climate & Energy [7]

The climate crisis is the challenge of our time. We can fix it with solutions that will make us healthier and more economically secure. We must act quickly to make our economy run on renewable power — and ensure that disadvantaged families and displaced workers share equitably in the new economy. We also must fight the corrupting power of fossil fuel companies and ensure that energy regulators are effective and publicly accountable.

Tell Toyota: Go all-in on EVs

Add Your Name

Climate Roadmap for U.S. Financial Regulation

Toyota’s Troubling Electric Vehicle Track Record
Justice & the Courts [8]

Litigation can remedy or deter wrongdoing, impact policy and meaningfully slow abuses of power. Whether suing on behalf of our members to ensure the honest functioning of government, or representing individual consumers seeking redress in court, our litigation draws on our expertise in administrative law, constitutional law, and government transparency.

Subscribe to the Supreme Court Conference Preview

Sign Up

Device Promotion

More Information on Device Promotion

Comments to the FDA on Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Products, April 19, 2017
Testimony Before the FDA’s Public Hearing on Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Products, November 9, 2016
Follow-up Letter to the Texas Medical Board Regarding the LipoTron Device, March 25, 2013
Press Release: Good Move, But Years Late: FDA Warns Maker of ‘Fat-Burning’ Device to Stop Marketing Unapproved Product, March 19, 2013
Letter to the Oklahoma State Department of Health Regarding the LipoTron Device, August 3, 2012
Letter to the Oklahoma Board of Osteopathic Examiners Regarding the LipoTron Device, August 3, 2012
Letter to the Oklahoma Board of Medical Licensure and Supervision Regarding the LipoTron Device, August 3, 2012
Letter to the Alabama Department of Public Health Regarding the LipoTron Device, August 3, 2012
Letter to the Alabama Board of Medical Examiners Regarding the LipoTron Device, August 3, 2012
Letter to the Medical Board of California Regarding the LipoTron Device, August 3, 2012
Letter to the Texas Department of State Health Services regarding the LipoTron Device, August 1, 2012
Letter to the Texas Medical Board regarding the LipoTron Device, August 1, 2012
Letter to Arkansas Department of Health regarding the LipoTron Device, July 30, 2012
Letter to Arkansas State Medical Board regarding the LipoTron Device, July 30, 2012
Letter to the Michigan Department of Community Health regarding the LipoTron Device, July 26, 2012
Letter to the Florida Department of Health Regarding the LipoTron Device, July 26, 2012
Letter to the Florida Board of Medicine Regarding the LipoTron Device, July 26, 2012
Follow-Up Letter to FDA Regarding LipoTron Device, July 23, 2012
Letter to the New Jersey State Board of Medical Examiners Regarding the LipoTron Device, July 23, 2012
Letter to the FDA Regarding the Apparent Illegal Marketing and Promotion of the LipoTron Medical Device, July 18, 2012
Comments on Draft Guidance for Industry on Off-Label Promotion of Drugs and Medical Devices, April 21, 2008
Letter Requesting the Halt of Ads for Vagus Nerve Stimulator Device, May 18, 2006

Stay Updated on Public Citizen

Follow Public Citizen

Support Our Work

Donate

Menu

Tell Congress: Pass the Protecting Our Democracy Act

Generative Artificial Intelligence and Threats to Democracy

Protecting Elected Officials from Threats

Get Corporate Money Out of Politics

It’s Time to Cut the Bloated Pentagon Budget to Fund People, Not Military Contractors

Ensuring Public Money Does Not Go To Private Equity

Don’t Let Big Tech Write Our Digital Privacy Laws

Public Citizen Calls on Presidential Candidates, Parties to Pledge Not to Use Dangerous, Manipulative Deepfakes

Within Reach: Banker Pay Reform

Tell President Biden: Make Meds Affordable

Win Medicare for All

Report: Ranking of the Rate of State Medical Boards’ Serious Disciplinary Actions, 2019-2021

Petition to the FDA to Strengthen Safety Warning for Botox and Related Drugs and Remove Misleading Claims From Botox/Botox Cosmetic Labeling

President Biden: No Secrecy in Indo-Pacific Trade Talks

Climate Peace Clause Needed to Stop Trade Attacks on Climate Policies

Big Tech’s “Digital Trade” Power-Grab

Tell Toyota: Go all-in on EVs

Climate Roadmap for U.S. Financial Regulation

Toyota’s Troubling Electric Vehicle Track Record

Subscribe to the Supreme Court Conference Preview

Share

Device Promotion

Share

More Information on Device Promotion

You might be interested in

Comments on the FDA’s Proposed Voluntary Malfunction Summary Reporting Program for Manufacturers

Device Policy

Device Reporting Requirements

Letter to Congress Opposing Legislation That Would Expand Promotion of Drugs for Unapproved Uses

Stay Updated on Public Citizen

Follow Public Citizen

Support Our Work